Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
OWNS | <0.01% | $129.31M | 0.3% |
GSST | -<0.01% | $921.46M | 0.16% |
FEMB | -0.03% | $203.14M | 0.85% |
GSY | -0.07% | $2.74B | 0.22% |
FXC | 0.09% | $93.16M | 0.4% |
RING | 0.12% | $1.44B | 0.39% |
CORN | -0.14% | $44.67M | 0.2% |
IBDR | 0.16% | $3.34B | 0.1% |
TOTL | 0.22% | $3.84B | 0.55% |
NFLT | 0.30% | $269.84M | 0.5% |
IBDS | 0.31% | $3.14B | 0.1% |
STXT | -0.32% | $129.40M | 0.49% |
SPTI | 0.33% | $8.82B | 0.03% |
IBTM | 0.36% | $316.49M | 0.07% |
AGZ | 0.37% | $614.58M | 0.2% |
KCCA | -0.38% | $109.43M | 0.87% |
MTBA | 0.38% | $1.37B | 0.17% |
TYA | 0.39% | $152.69M | 0.15% |
VGIT | -0.44% | $31.89B | 0.04% |
FLDR | 0.45% | $941.22M | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -22.68% | $296.22M | 1.43% |
VIXY | -18.37% | $164.54M | 0.85% |
TAIL | -14.86% | $99.63M | 0.59% |
GBIL | -11.37% | $6.37B | 0.12% |
PSQA | -10.93% | $35.44M | 0.2% |
XHLF | -9.81% | $1.73B | 0.03% |
TBLL | -9.64% | $2.13B | 0.08% |
FXY | -7.84% | $816.38M | 0.4% |
SGOV | -7.02% | $49.21B | 0.09% |
IBTF | -6.64% | $1.99B | 0.07% |
IVOL | -6.61% | $347.03M | 1.02% |
XONE | -6.39% | $625.28M | 0.03% |
MINT | -5.55% | $13.37B | 0.35% |
USFR | -5.52% | $18.56B | 0.15% |
IBTG | -5.36% | $1.92B | 0.07% |
UTWO | -4.94% | $379.52M | 0.15% |
BILS | -4.87% | $3.81B | 0.1356% |
STOT | -4.82% | $254.07M | 0.45% |
UNG | -4.68% | $360.54M | 1.06% |
BIL | -4.46% | $42.24B | 0.1356% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PLAB | 31.85% | $1.21B | -19.94% | 0.00% |
OKTA | 29.19% | $17.18B | +4.64% | 0.00% |
GPCR | 27.43% | $1.18B | -45.42% | 0.00% |
CMCO | 26.94% | $468.15M | -51.54% | 1.70% |
CC | 26.10% | $1.91B | -43.90% | 6.50% |
CDNS | 25.68% | $84.90B | -1.43% | 0.00% |
FWONK | 25.35% | $25.57B | +39.93% | 0.00% |
AI | 24.78% | $3.47B | -9.59% | 0.00% |
OC | 24.73% | $12.38B | -13.53% | 1.77% |
RGNX | 24.37% | $434.35M | -20.33% | 0.00% |
TROX | 24.15% | $876.30M | -66.20% | 8.96% |
RARE | 24.14% | $3.73B | -1.87% | 0.00% |
XNCR | 24.05% | $590.72M | -55.40% | 0.00% |
RCUS | 23.72% | $909.55M | -40.18% | 0.00% |
AOS | 23.66% | $9.68B | -15.98% | 1.96% |
TBCH | 23.46% | $292.02M | +2.29% | 0.00% |
ROIV | 23.30% | $7.46B | +4.68% | 0.00% |
ABEO | 23.19% | $300.29M | +34.94% | 0.00% |
BPMC | 23.18% | $8.29B | +17.58% | 0.00% |
PDFS | 22.99% | $884.56M | -37.34% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 25.16% | $4.82B | 0.35% |
CPRJ | 23.59% | $48.26M | 0.69% |
IBB | 21.99% | $5.26B | 0.45% |
UOCT | 21.89% | $161.92M | 0.79% |
BUFD | 21.81% | $1.32B | 0.95% |
UDEC | 21.65% | $410.46M | 0.79% |
MJ | 21.61% | $100.97M | 0.76% |
IHAK | 21.56% | $951.11M | 0.47% |
QAI | 21.45% | $708.25M | 0.91% |
YOLO | 21.40% | $24.65M | 1.12% |
CNBS | 21.12% | $55.77M | 0.77% |
RDTE | 21.07% | $137.93M | 0.97% |
BUFZ | 20.81% | $520.81M | 0.95% |
IWC | 20.77% | $818.14M | 0.6% |
QDVO | 20.77% | $83.43M | 0.55% |
KJUL | 20.76% | $119.50M | 0.79% |
IWMY | 20.53% | $119.32M | 1.02% |
PAUG | 20.41% | $783.30M | 0.79% |
PFUT | 20.41% | $359.99M | 0.65% |
IAI | 20.38% | $1.38B | 0.4% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MNRO | -29.52% | $498.69M | -27.68% | 6.74% |
BOX | -28.98% | $4.75B | +25.80% | 0.00% |
NTZ | -17.64% | $39.32M | -25.63% | 0.00% |
VSTA | -15.21% | $344.07M | +39.29% | 0.00% |
PACB | -13.30% | $447.13M | +14.62% | 0.00% |
PPC | -12.51% | $10.84B | +33.46% | 0.00% |
KR | -9.67% | $46.43B | +38.38% | 1.85% |
ANF | -9.10% | $4.28B | -50.01% | 0.00% |
MTN | -8.81% | $6.11B | -4.60% | 5.40% |
JOBY | -8.77% | $8.04B | +97.28% | 0.00% |
AZO | -8.65% | $61.65B | +29.54% | 0.00% |
ALLO | -8.55% | $262.48M | -42.31% | 0.00% |
NOC | -8.44% | $71.81B | +14.14% | 1.69% |
SLE | -8.39% | $4.57M | -84.82% | 0.00% |
NHTC | -8.18% | $52.73M | -34.10% | 17.43% |
UNH | -8.16% | $279.00B | -37.22% | 2.74% |
HOLX | -7.91% | $14.55B | -11.13% | 0.00% |
PGNY | -7.81% | $1.82B | -24.84% | 0.00% |
COR | -7.58% | $56.44B | +30.86% | 0.74% |
PLUG | -7.52% | $1.61B | -43.32% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BYON | -0.01% | $440.09M | -38.91% | 0.00% |
FYBR | 0.02% | $9.13B | +39.74% | 0.00% |
ABT | 0.03% | $233.33B | +31.06% | 1.70% |
LBRDA | 0.03% | $14.17B | +82.29% | 0.00% |
JBSS | -0.04% | $780.55M | -29.37% | 1.28% |
JJSF | 0.04% | $2.32B | -27.53% | 2.61% |
CQP | 0.09% | $27.02B | +12.31% | 5.88% |
BCE | 0.09% | $21.07B | -27.36% | 10.97% |
MGPI | 0.10% | $699.20M | -54.61% | 1.45% |
BFAM | 0.12% | $6.92B | +9.87% | 0.00% |
MDLZ | -0.12% | $90.07B | +4.85% | 2.72% |
BTI | 0.13% | $103.67B | +50.78% | 6.33% |
ABEV | 0.13% | $38.96B | +19.71% | 5.28% |
U | -0.13% | $10.09B | +54.35% | 0.00% |
LAB | -0.14% | $520.36M | -25.54% | 0.00% |
WTW | -0.15% | $30.19B | +16.95% | 1.18% |
WPC | 0.15% | $13.87B | +15.36% | 5.60% |
CWCO | 0.16% | $492.46M | +26.08% | 1.51% |
TEVA | -0.17% | $19.55B | +1.37% | 0.00% |
SYPR | 0.19% | $48.49M | +14.05% | 0.00% |
Current Value
$0.811 Year Return
Current Value
$0.811 Year Return
Yahoo
With policy and funding evolving, companies are being forced to rethink strategies.
Yahoo
JENA, Germany, May 28, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Independent Data Monitoring Committee (IDMC) conducting the unblinded interim analysis for the Phase 3 trial for vilobelimab in pyoderma gangrenosum (PG), recommended that the trial be stopped due to futility. This recommendation was based on data analysis of the first 30 patients enrolled in t
Finnhub
InflaRx N.V. announced that the Independent Data Monitoring Committee conducting the unblinded interim analysis for the Phase 3 trial for Vilobelimab in pyoderma gangrenosum , recommended that the...
Yahoo
JENA, Germany, May 22, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will participate in multiple investor conferences in June and July 2025. Jefferies Global Healthcare ConferenceJune 3 - 5, 2025 in New York, NY InflaRx will conduct an investor presentation on June 4th at 7:35 AM ET and will participate in one-on-one investor meetings. A link to regi
Finnhub
Certain Pre-Funded Warrants of InflaRx N.V. are subject to a Lock-Up Agreement Ending on 15-MAY-2025. These Pre-Funded Warrants will be under lockup for 91 days starting from 13-FEB-2025 to...
Finnhub
Certain Options of InflaRx N.V. are subject to a Lock-Up Agreement Ending on 15-MAY-2025. These Options will be under lockup for 91 days starting from 13-FEB-2025 to 15-MAY-2025. Details: The...